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Transition of proliferative to membranous glomerulonephritis in
chronic serum sickness. Chronic serum sickness glomerulonephritis was
induced in rats by daily i.v. administration of bovine serum albumin
(BSA). Previous studies have shown that the disease progresses
through three discrete stages: mild, moderate and severe. The diffuse,
proliferative necrotizing glomerulonephntis of severe chronic serum
sickness, which is accompanied by a decreased glomerular filtration
rate and increased glomerular permeability to macromolecules, has an
inevitable fatal outcome. In the experiments reported here, BSA
injections were discontinued at the transition from moderate to severe
glomerulonephritis, a point which was identified by decreased sodium
excretion. Retrospectively, rats could be divided into two categories.
Some, called non-survivors, continued to exhibit sodium retention.
Those animals progressed rapidly to end—stage renal disease and died
within two weeks of the cessation of antigen injections. Others, called
survivors, returned to sodium balance and remained alive for many
months. The development of progressive membranous glomerulone-
phritis, with prominent spike formation and disappearance of glomeru-
lar hypercellularity, was noted in all survivors. That change in
histopathology occurred in the absence of both circulating BSA and
precipitating antibodies to BSA. The transition of proliferative to
membranous glomerulonephritis was accompanied by partial recovery
of glomerular function, although proteinuria persisted. Maintenance of
severe proteinuria did not appear to depend on an active immunological
process.
The immune complex glomerulonephritis of chronic serum
sickness can be produced in rats by daily immunization with
bovine serum albumin (BSA) [1]. The disease progresses
through three discrete stages designated mild, moderate and
severe [21. Characteristics of pathophysiology and im-
munopathology distinguishing each of these stages have been
described in detail in earlier publications [2, 3]. If daily intra-
venous injections of low doses of BSA are continued, the
diffuse proliferative necrotizing glomerular lesion of severe
chronic serum sickness, which is accompanied by a decreased
glomerular filtration rate (GFR), massive proteinuria and fluid
retention, results in the death of all individuals [2, 4]. In other
animal models of chronic serum sickness, administration of
excess antigen has been shown to be effective in removing
immune complex deposits from glomeruli [5, 6]. In contrast,
little is known about the natural fate of those immune com-
plexes if antigen administration is discontinued instead.
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We wished to determine whether the functional deficits
and/or the histopathology of chronic serum sickness nephritis
would improve or become progressively worse in the absence
of daily exposure to BSA. From preliminary experiments, we
had learned that discontinuation of daily intravenous injections
of BSA in rats with ascites fluid accumulation, which had
reached the severe stage, did not alter the fatal outcome of
chronic serum sickness nephritis. Therefore, we attempted to
stop antigen injections at the point of transition from moderate
to severe chronic serum sickness which we had found to be
most clearly marked by an abrupt decrease in sodium excretion
[2]. For that reason, in this study urinary sodium concentration
and excretion were monitored frequently; daily BSA injections
were discontinued in individual rats at the first indication of
sodium retention. Retrospectively, the animals could be divided
into two categories. Some, called non-survivors, died within
two weeks despite the cessation of antigen injections, whereas
others, called survivors, showed gradual improvement in renal
function and were studied for several months.
In this report, kidney function and immunopathology in survi-
vors and non-survivors were compared in the weeks immediately
preceding and following discontinuation of antigen injections. In
addition, immunopathology and pathophysiology of animals sur-
viving longer than two months were also evaluated.
Methods
Animals. Female LEW rats weighing approximately 125 g,
purchased from Charles River Breeding Laboratories
(Wilmington, Massachusetts, USA), were used in this study.
Immunizations. To induce chronic serum sickness, rats were
given three subcutaneous injections of 3.0 mg BSA in incom-
plete Freund's adjuvant at two—week intervals. That immuni-
zation protocol resulted in the production of precipitating
antibodies to BSA with titers (expressed as log2 of the highest
serum dilution giving an unequivocal positive reaction) of three
to four, as detected by double diffusion gel precipitation tests
[1]. Daily intravenous injections of 2.0 mg BSA in 0.4 muter
isotonic saline were introduced gradually by a scheme de-
scribed in detail elsewhere [1]. These daily antigen injections
were discontinued at the transition from moderate to severe
stages of glomerulonephritis. Circulating anti-BSA antibody
titers were measured weekly by Ouchterlony immunodiffusion
tests [1].
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Table 1. Aspects of kidney functiona
Cereatinine UNa UNaV
mliter/mm (0.55) mEq/liter (40) mEg/24 hr (0.18)
Week" N-S S N-S S N-S S
—2 0.41 0.05 0.43 0.03 30.0 8.9 42.0 9.7 0.27 0.04 0.37 0.05
(9) (12) (9) (12) (9) (12)
—1 0.23 0.03'' 0,42 0.05 31.9 10.7 38.3 5.1 0.20 0.05 0.27 0.03
(9) (10) (10) (15) (11) (15)
0 0.15 0.01 0.28 0,03d 20.3 3,9c 39.0 7.7 0.13 0.01" 0.17 0.08"
(10) (12) (16) (13) (16) (13)
+1 0.14 Ø,02rd 0.29 0.04" 38.9 10.9 56.8 8.1 0.16 0.02" 0.30 0.12
(7) (16) (9) (17) (7) (17)
+8 — 0.42 0.12
(8)
— 63.3
(9)
14.6 — 0.22 0.05
(9)
The numbers in parentheses in the column headings represent normal values obtained in our laboratory for age—matched LEW female rats.
Comparable values have been published elsewhere [2, 4].
a Data are expressed as means SE. Excretion data are expressed per 100 gm of body weight, The numbers of individual animals used to obtain
each mean value are indicated in parentheses. V. urine flow rate; C, clearance; U, urine; P, plasma; N-S, non-survivors; 5, survivors.
Week 0 is time of discontinuation of antigen injections. (—) and (+) indicate the weeks before and after this time, respectively.
Significantly different from survivor at P C 0.05.
Significantly different from Week —2 at P C 0.05.
Table 2. Aspects of protein excretiona
UproteinV UaiuminV Capsule fluid albumin Sieving coefficient for albumin
(x 10) (10)mg/24 hr (0.35) mg/dliter (3)mg/24 hr (1.01)
Week" N-S S N-S S N-S S N-S S
—2 142±38 121±24 51±11 40± 8 11.3±3.0 7.l±L7 177± 68 97± 35
(9) (12) (9) (12) (9) (12) (9) (12)
—1 219÷13d 211÷26d 114±49 82± 13 21.1±4.0 20.5±8.8 468± 138 201± 99
0
(11) (15)
237 20d 176 25
(11) (15)
70 8 63 11
(9) (11)
31.2 3.0r4 17.9 3.8 (9) (11)703 113c,d 301 88"
(16) (13) (16) (13) (16) (13) (16) (13)
+1 196 34 171 19 49 9 65 10 26.8 4.5" 19.0 4.0" 1000 254c 400 109"
(7) (17) (7) (17) (9) (17) (9) (17)
+8 — 105±14 — 49± 6 — 11.2±3.1 — 135± 46
(9) (9) (10) (10)
The numbers in parentheses in the column headings represent normal values obtained in our laboratory for age—matched LEW female rats.
Comparable values have been published elsewhere [2, 4].
a Data are means sE. Excretion data are expressed per 100 gm of body weight. The numbers of individual animals used to obtain each mean
value are indicated in parentheses. Abbreviations are the same as Table 1.
"Week 0 is time of discontinuation of antigen injections. (—) and (+) indicate the weeks before and after this time, respectively.
Significantly different from survivor at P C 0.05.
"Significantly different from Week —2 at P C 0.05.
Kidney function. Urine was collected from animals kept in
metabolism cages for 16 hr with free access to water but
deprived of food. Blood samples were obtained from the tail
vein at the end of the collection period. Protein, sodium,
potassium and creatinine concentration were measured in these
samples. Excretion rates of protein and sodium and creatinine
clearance were determined.
A micro-continuous gradient gel eleetrophoresis procedure
was used for separation and quantitation of proteins in plasma
(diluted 1:51) and unconcentrated urine [7, 8]. This method
allows us to estimate total protein and albumin concentrations.
After electrophoresis the gels were extruded into acetic acid,
fixed, stained with Fast Green, destained, and scanned directly
in an ultramicrodensitometer (Joyce Loebl) with integrator unit.
Creatinine concentration in urine and plasma was analyzed
after adsorption and elution from Lloyd's reagent [91. Sodium
and potassium concentration in urine and plasma were mea-
sured by flame photometry (Klina Flame, Beckman Instru-
ments, Inc.). Values are given as the mean 1 sa. Student's
test was used for statistical analysis.
Immunopathology. Kidney tissue samples obtained at the
time of death were processed for evaluation by im-
munofluorescence and light microscopy. Direct immunofluores-
eence tests were performed on frozen sections of rat kidney to
determine the sites of deposition of immune reactants. FITC-
conjugated antisera to BSA, rat immunoglobulins and rat com-
plement were purchased from Cappel Laboratories (Cochran-
ville, Pennsylvania, USA), FITC-conjugated BSA to detect
antibodies to BSA was prepared in our laboratory [10]. The
extent of deposition of IgG, C3, BSA and anti-BSA was judged
on a scale from 0 to 3.
Kidney tissue samples were fixed by immersion in 10%
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Table 3. Plasma compositiona
Fprotem Pabun,j, Pcatjnine PNa
lIfter (144)
PK
mEqlliter (5.3)g/dliter (6.6) gldliter (3.4) mg/dliter (0.49) mEq
Weekb N-S S N-S S N-S S N-S S N-S S
—2 5.1 0.5 5.6 0.4 1.1 0.2 1.3 0.2 0.56 0.04 0.54 0.03 143 3 148 1 6.2 0.1 6.2 0.2
(9) (12) (9) (12) (9) (12) (9) (12) (4) (8)
—1 4.6 0.2 5.9 0.5 0.6 0.1" 1.2 0.3 0.76 0.07°" 0.54 0.02 144 2 147 3 6.1 0.3 5.7 0.2
(9) (11) (9) (11) (9) (10) (9) (11) (7) (8)
0 4.1 0.4 4.9 0.3 0.5 0.1°"' 0.8 0.1 0.99 0.06°" 0.63 0.03 148 1 147 2 6.1 0.3 6.5 0.3
(10) (12) (10) (12) (10) (12) (10) (12) (6) (7)
+1 3.2 0.2°" 45 o3d 0.3 0.04°"' 0.7 0.1 0.79 004c,d 0.58 0.04 148 1 142 3 6.1 0.2 6.0 0.4
(7) (17) (7) (17) (7) (16) (7) (17) (5) (11)
+8 — 6.4 0.5 — 1.3 0.2 — 0.54 0.13 — 141 2 — 5.7 0.3
(10) (10) (8) (10) (7)
The numbers in parentheses in the column headings represent normal values obtained in our laboratory for age—matched LEW female rats.
Comparable values have been published elsewhere [2, 41.
a Data are means sE. The numbers of individual animals used to obtain each mean value are indicated in parentheses. Abbreviations are the
same as Table 1.
b Week0 is time of discontinuation of antigen injections. (—) and (+) indicate time before and after week 0, respectively.
Significantly different from week —2 at P < 0.05.
d Significantly different from survivor at P < 0.05.
Fig. 1. Light micrograph of a glomerulus of a non-survivor rat at Week
0, the time antigen injections were discontinued. The histopathology
resembles that of severe chronic serum sickness nephritis. The en-
larged, lobulated glomerulus shows severe endocapillary hypercellular-
ity. The glomerular basement membrane is of normal thickness. Silver
methenamine. x 800.
buffered formalin and embedded in paraffin. Sections 4 p. thick
were stained with hematoxylin—eosin, periodic acid Schiff rea-
gent and methenamine silver for examination by light micros-
copy. For electron microscopy small pieces of kidney cortex
were fixed in a mixture of paraformaldehyde and glutaraldehyde
[11], post fixed in 1% osmium tetroxide and embedded in Epon
812-Araldite. Thin sections were stained with uranyl acetate
and lead citrate.
Design of experiment. Kidney function of individual rats was
studied in detail from the time each developed the proteinuria
(>25 mg/24 hr x 100 g body wt (BW) ) that is characteristic of
moderate chronic serum sickness [2]. Antigen injections were
FIg. 2. Light micrograph of a glomerulus of a survivor rat at Week 0, the
time antigen injections were discontinued. Hypercellularity (difficult to
see in this picture because of the type of staining used) is accompanied
by an increase in mesangial matrix. The glomerular basement mem-
brane is of normal thickness. Silver methenamine. X 800.
discontinued at the earliest indication of decreased sodium
excretion, a change that marks the transition from moderate to
severe chronic serum sickness [2]. Kidney function of each
animal was assessed weekly until the animal died spontane-
ously or was killed to obtain tissue for evaluation of im-
munopathology. As some variation was observed among indi-
viduals in the time of onset of measurable sodium retention, the
day on which BSA injections were stopped was different for
each rat. For that reason, data for individuals have been pooled
by group (non-survivor or survivor), relative to the week in
which antigen injections were halted. The week in which
decreased sodium excretion was first measured (and, hence,
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Fig. 3. Electron micrograph of part of a glomerulus of a nonsurvivor rat at Week 0, the time antigen injections were discontinued, A capillary lumen
is obstructed by cells (asterisks), Electron dense deposits are seen at both sides of the glomerular basement membrane and in the mesangium (M).
Most of the foot processes of the visceral epithelial cells (EP) have disappeared. BS, Bowman's space. x 4000. Inset. Immunofluorescence
micrograph of a glomerulus of the same rat. Ribbon—like deposits of rat IgG are present along the glomerular capillary wall. In addition, fine
granular deposits are seen in the mesangium. x 800.
antigen administration stopped) for an individual rat was des-
ignated Week 0, the week before, Week —1, and the week after,
Week + 1, etc. The mean length of time (9 weeks) between the
start of intravenous BSA injections and Week 0 was the same
for survivors and non-survivors. Kidney function in survivors
appeared to reach a stable, unchanging state by Week +8,
although many animals were studied for much longer periods
(up to Week + 15).
Kidney tissue for study of immunopathology was obtained
from rats that were killed for that purpose at Weeks —1, 0, +2,
+4, and +6, and assigned retrospectively, on the basis of
kidney function, to the survivor group. A minimum of three
samples were studied for each week; six samples were taken
between Week —1 and Week 0. In addition, nine samples were
studied from animals followed for eight weeks or more. Simi-
larly, kidney tissue samples were obtained in Week 0 from 5
rats, identified as belonging to the non-survivor group on the
basis of kidney function, and from seven other non-survivors at
the time of spontaneous death in the next two weeks.
Results
Pathophysiology
Two weeks before BSA injections were stopped (Week —2)
survivors and non-survivors were indistinguishable with respect to
kidney function (Tables 1, 2). Kidney function and plasma com-
position (Tables 1, 2, 3) in both groups were similar to previously
published values for moderate CSS [2, 4]. Protein excretion was
significantly elevated and plasma albumin concentration signifi-
cantly decreased compared to values in normal female LEW rats.
Increased glomerular permeability was also reflected in the cap-
sule fluid albumin concentration and the sieving coefficient for
albumin which were elevated in all rats. The sieving coefficient for
albumin ((U:P)bumju/(U:P)creatjnjne) and capsule fluid concentra-
tion can be calculated if the assumption is made that reabsorption
of albumin is negligible when the excretion rate is markedly
elevated [12]. Creatinine clearance was well maintained and
sodium excretion was within normal limits [2, 4].
One week before discontinuation of antigen injections (Week
—1), non-survivors exhibited significantly decreased creatinine
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was approximately 120 mg/24 hr x 100 g BW, comparable to
that seen in animals at Week —2.
Immunopathology
Fig. 4. Light micrograph of a glomerulus from a rat killed eight weeks
after BSA administration was discontinued. The glomerular basement
membrane is thickened and "spikes" are present at its epithelial side.
Silver methenamine. x 800. Inset. At high magnification spikes are
clearly visible at the epithelial side of the basement membrane of
glomerular capillary ioops. Silver methenamine. x 1200.
clearances and elevated plasma creatinine concentrations, indi-
cating a more severe compromise of kidney function than the
survivor group. However, mean sodium excretion, the criterion
used in this experiment to monitor the transition from moderate
to severe chronic serum sickness was not different, nor was any
other parameter that we measured.
Week 0 was, by definition, the time at which decreased
sodium excretion was first detected; mean values for sodium
excretion were significantly decreased in both groups. Glomer-
ular filtration rate (GFR), as estimated from creatinine clear-
ances, was decreased in both groups, although GFR of non-
survivors was significantly more depressed.
At week 0, non-survivors exhibited significantly increased
glomerular permeability to albumin compared to survivors, as
evidenced by the increase in capsule fluid albumin concentra-
tion and sieving coefficient (Table 2). Decreased plasma albu-
min concentration (Table 3) in non-survivors reflects this renal
loss. Any possible further increase in albumin excretion was
limited by the low plasma albumin concentration. At all weeks,
the capsule fluid albumin concentration and albumin sieving
coefficient of survivors were similar to those previously deter-
mined for rats in the moderate stage of CSS [2].
The severe impairment of renal function, exhibited at Week 0
by the non-survivors, persisted despite cessation of BSA injec-
tions, resulting in the death of all animals in that group by Week
+2. In contrast, the depressed sodium excretion of survivors
returned to normal by Week +1. Other measurements reflecting
kidney function did not change significantly, indicating an arrest
in the decline in function that proceeded unabated in the
non-survivor group. By Week +4, creatinine clearance had
improved to a value similar to that measured at Week —2 (0.43
0.05 mliter/min x 100 g BW). In the period from Week + 1 to
Week +8, survivors showed progressive decrease in glomerular
permeability to protein. However, abnormal elevation of pro-
tein excretion persisted for the duration of the study (Week
+ 15). The average protein excretion for Weeks 9 through 15
Histopathology of the kidneys of nonsurvivors at Week 0
resembled that previously described for rats in the severe stage
of chronic serum sickness [2]. Severe hypercellularity, infiltra-
tion of neutrophils and monocytes, and necrotizing lesions were
observed in all glomeruli; the glomerular basement membrane
did not appear to be thickened (Fig. 1). Inspissated casts were
present in many tubules; tubule degeneration or atrophy was
widespread; focal inifitration of the interstitium with mononu-
clear cells was seen. At Week 0 kidneys of survivors had lesions
characteristic of moderate chronic serum sickness [2].
Hypercellularity, an influx of neutrophils, and widening of the
mesangial stalk were the major aspects of glomerular pathology
(Fig. 2); the glomerular basement membrane was of normal
thickness and spikes were not observed. Crescent formation
was not a feature of the disease. Degenerative changes were
noted in some tubules containing proteinaceous casts. How-
ever, at Week 0 it was not possible to distinguish survivors from
non-survivors by means of direct immunofluorescence tests. At
that time glomeruli of all rats displayed intense immunofluores-
cence (3+) for IgG, C3, BSA and anti-BSA [1, 2]; extra—glomer-
ular immune deposits were not observed. Furthermore, by
electron microscopy dense deposits were observed in subepi-
thelial, subendothelial and mesangial sites in both survivors and
nonsurvivors at Week 0 (Fig. 3).
No significant changes in immunopathology were noted in
non-survivors from Week 0 to Week +2, by which time all had
died. However, in survivors small spikes at the epithelial side of
the glomerular basement membrane were noted as early as
Week + 2; other aspects of the kidney pathology were similar to
those observed at Week 0. In the weeks that followed, promi-
nent spike formation resulted in a diffuse thickening of the
glomerular capillary wall (Fig. 4) that was evident in all indi-
viduals from Week +8 and later. By Week +8, the endocapillary
hypercellularity and infiltration with neutrophils had completely
disappeared in all but an occasional animal that showed focal,
mild mesangial hypercellularity; the glomerular capillary lumina
were wide open. All survivor animals developed moderate to
pronounced mesangial sclerosis by Week +8 (Fig. 5). In addi-
tion, in about 20% of the rats, segmental sclerosis and hyaliniza-
tion were found in about 10% of the glomeruli (Fig. 5, inset).
The animals with slightly more severe glomerular histopathol-
ogy did not appear to suffer more severe kidney dysfunction
than other survivors. The observation period was too short to
evaluate whether the scierosing process in the survivors even-
tually leads to end—stage kidney disease. Despite the presence
of casts in a few tubules, the majority of tubules and the
interstitium appeared normal. A gradual diminution in intensity
of immunofluorescence staining with the passage of time was
observed in survivors. After 8 weeks IgG deposits were judged
to be of 2+ intensity, BSA and anti-BSA staining were assigned
a mean score of 1.5 and 1.0, respectively (Fig. 6). In contrast,
deposits of C3 disappeared more rapidly and were completely
undetectable in the glomeruli of survivors by Week +8. By
electron microscopy, dense deposits in the capillary wall of
survivors became increasingly difficult to distinguish as the
deposits appeared to become incorporated in the basement
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Fig. 5. Electron micrograph of part of a glomerulus of a rat killed 11 weeks after BSA administration was discontinued. The glomerular basement
membrane is irregularly thickened and contains barely visible electron dense deposits (asterisks). The mesangium (M) is affected by a scierosing
process. The epithelial foot process system has partially disappeared. Abbreviations are: CL, capillary lumen; EP, visceral epithelial cell; R, red
blood cell. x 5000. Inset. Light micrograph of part of a glomerulus of the same rat, showing segmental hyalinization and sclerosis. PAS. x 800.
membrane material, acquiring a density similar to that of the
thickened basement membrane itself; subendothelial and
mesangial immune deposits were absent (Fig. 5, 6).
Antibodies to BSA, which had a mean titer (log2) of 3.2 at the
time intravenous antigen injections were begun, were not
detectable by immunoprecipitation tests in gel when daily BSA
injections were discontinued. Those precipitating antibodies
were not detectable in the serum of survivors at any time
afterwards.
Discussion
With discontinuation of antigen injections the proliferative
glomerulonephritis observed at the transition from moderate to
severe chronic serum sickness transforms into membranous
glomerulonephritis. That change in histopathology is accompa-
nied by improvement in sodium balance, glomerular filtration
rate and glomerular permeability to macromolecules, but pro-
teinuria and other aspects of nephrotic syndrome (hyperlipid-
emia, hypoalbuminemia) persist. In contrast, severe chronic
serum sickness, accompanied by persistent sodium retention,
has an inevitable fatal outcome that cannot be prevented by
eliminating daily antigen exposure.
Although transitions among the histological classes of human
lupus nephritis, for which experimental chronic serum sickness
may be considered a laboratory model, was once thought to be
uncommon, there is growing evidence that transitions may
occur fairly frequently [13—151. The transformation of a number
of lupus patients from WHO class IV to class V, described by
Lee et al [15], is very similar to the transformation from
proliferative moderate chronic serum sickness to membranous
glomerulonephritis that we have described here. Discontinua-
tion of daily BSA injections, which resulted in the development
of membranous glomerulonephritis in chronic serum sickness,
was accompanied by an apparent resolution of the inflammation
in glomeruli. Gradual disappearance of complement and
blood—borne cells from glomeruli were clear evidence of de-
creased inflammation. In addition, inflammatory cell infiltration
of the kidney interstitium was also much reduced in long—term
survivors.
Regardless of the mechanisms by which they form, immune
complex deposits in tissue may be extensively modified subse-
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Fig. 6. Electron micrograph of part of a glomerulus of a rat killed six weeks after BSA administration was discontinued. A thickened glomerular
basement membrane shows many subepithelial projections of basement membrane—like material (spikes). In between the spikes, deposits
(asterisks) that are only slightly more dense than the surrounding basement membrane are visible. Only part of the epithelial foot process system
is intact. Abbreviations same as Fig. 5. x 5000. Inset. Immunofluorescence micrograph of a glomerulus of the same rat. Weakly staining granular
deposits of rat IgG are located in the periphery of the capillary tuft. x 200.
quently [6, 16]. Factors that have been implicated in such
modifications include additional antigen, antibody and comple-
ment, which are the molecular components of the original
deposits. Antibodies directed against constituents of the im-
mune complexes, such as rheumatoid factors, anti-idiotype
antibodies and C3 nephritic factor, could also alter the compo-
sition and appearance of the deposits. In rats with chronic
serum sickness, the impressive alteration in appearance and
distribution of immune deposits that was associated with the
transformation of proliferative into membranous lesions oc-
curred in the absence of any detectable circulating antigen.
Furthermore, the membranous glomerulonephritis described
here evolved in the absence of precipitating antibodies to BSA.
We also think it unlikely that secondary autoimmune responses
contributed to immune complex modification in this model.
Immune deposits were not observed to grow after BSA injec-
tions were discontinued. On the contrary, intensity of direct
immunofluorescence tests for all immune complex components
decreased after Week 0. Inflammatory processes in glomeruli
appeared to resolve. Rheumatoid factors could not be detected
in sera from rats with chronic serum sickness, either before or
after antigen injections were stopped (Noble and Milgrom,
unpublished observations).
The transformation of proliferative into membranous lupus
nephritis has been correlated with the appearance of
nonprecipitating anti-DNA antibodies [17]. Low concentrations
of non-precipitating anti-BSA antibodies of low affinity also
predominate in the sera of rats with advanced chronic serum
sickness (Steward and Noble, unpublished observations). In
lupus nephritis modification of antibody responses, from pre-
cipitating to nonprecipitating, has been observed during treat-
ment with corticosteroids [17, 18]. Therefore, it has not been
possible to rule out an essential role of drug therapy in the
histopathological transformation of lupus nephritis. The obser-
vation, that the change of proliferative into membranous
chronic serum sickness glomerulonephritis may occur in rats in
the absence of steroid treatment, makes it clear that drugs are
not essential to produce that particular modification of immune
complex pathology and supports the view that nonprecipitating
antibodies are important.
The disappearance of immune deposits from mesangial and
subendothelial sites could have resulted from phagocytic activ-
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ity ofcells in thç mesangium, both residential and blood—borne.
In any event, sclerotic charges in the mesangium of survivors
appeared to be sequelae of immune deposition. We were
interested to note that immune deposits in subepithelial loca-
tions in glomeruli of survivors did not acquire the "moth—
eaten" aspect, often attributed to deposit dissolution, that is
characteristic of the membranous lesion in late stages of
Heymann nephritis [19]. Instead, the epimembranous deposits
in chronic serum sickness survivors appeared to become incor-
porated into the increasingly thickened glomerular basement
membrane, a process that may reflect altered synthesis of
basement membrane components. The different fates of subepi-
thelial immune deposits in Heymann nephritis and chronic
serum sickness under similar conditions (decreasing circulating
antibody titers and disappearance of complement from the
deposits) suggest that the deposits in each disease may be
fundamentally different in mechanism of formation, in compo-
sition and/or in their effect on the glomerular environment.
Although in previous studies we had identified decreased so-
dium excretion as an unequivocal indication of the onset of severe
chronic serum sickness, it appears, from the data reported here,
that decrease in GFR may serve as an earlier and equally reliable
index of the transition from moderate to severe chronic serum
sickness. Decreased GFR has also been observed to mark the
onset of exacerbations in severe proliferative lupus nephritis [201;
remissions in patients were accompanied by improvement in
GFR, which we have also noted in long term survivors. As a result
of discontinuing antigen injections, it became clear that only a few
days' time and rather small absolute differences in many aspects of
kidney function (GFR, sodium balance, glomerular permeability
to macromolecules) separate animals fated to die with chronic
serum sickness glomerulonephritis from those that survive with
gradually improving renal function. This phenomenon is consist-
ent with our earlier observation that transitions between stages of
chronic serum sickness nephritis are sharply delineated, occurring
as discrete and relatively sudden events, rather than as gradual
changes.
The value of experimental chronic serum sickness as a model
for lupus nephritis has been extended by our observation that at
least one of the puzzling transformations of histopathology seen in
lupus nephritis can also be produced in the laboratory. One set of
conditions has been identified (absence of antigen, no precipitating
antibody) under which, in the absence of therapy, proliferative
lesions may evolve into membranous nephropathy. Furthermore,
our experiments indicate that, while some improvement in GFR
and macromolecular permeability may be achieved when active
inflammatory processes resolve, the nephrotic syndrome persists.
It wifi now be of some interest to study changes in im-
munopathology and pathophysiology of chronic serum sickness
that are the consequences of attempts to alter the course of the
disease, including reimmunization with BSA to produce exacer-
bations, regulation of diet and introduction of immunosuppressive
and anti-inflammatory drugs. Micropuncture studies of rats with
severe chronic serum sickness have revealed significant decreases
in whole kidney and single nephron glomerular filtration rates. It
will be interesting to determine whether the improvement of GFR
in survivors results from a uniform increase in GFR in all nephrons
or hyperfiltration associated with the development of glomerular
sclerosis in some nephrons.
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